The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Development of a new permeability assay using low‐efflux MDCKII cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80072-1 · Cited by 2,396
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Artursson, P., Palm, K., & Luthman, K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00128-9 · Cited by 1,543
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304
MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803205 · Cited by 980
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Smith, D. A., Di, L., & Kerns, E. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3287 · Cited by 898
Self-citationDrug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization
Kerns, E. H., & Di, L. (2016) · Cited by 784
Self-citationRational Use of in Vitro P-glycoprotein Assays in Drug Discovery
Polli, J. W., Wring, S. A., Humphreys, J. E., Huang, L., Morgan, J. B., Webster, L. O., & Serabjit-Singh, C. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29270-3 · Cited by 662
Physicochemical Profiling (Solubility, Permeability and Charge State)
Avdeef, A. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013395100 · Cited by 587
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M.-L., Lee, V. H. L., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1016473601633 · Cited by 571
Kamiie, J., Ohtsuki, S., Iwase, R., Ohmine, K., Katsukura, Y., Yanai, K., Sekine, Y., Uchida, Y., Ito, S., & Terasaki, T. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9532-4 · Cited by 478
In vitro models for the blood–brain barrier
Garberg, P., Ball, M., Borg, N., Cecchelli, R., Fenart, L., Hurst, R. D., Lindmark, T., Mabondzo, A., Nilsson, J. E., Raub, T. J., et al. (2005) · Toxicology in Vitro · doi:10.1016/j.tiv.2004.06.011 · Cited by 394
High throughput physicochemical profiling for drug discovery
Kerns, E. H. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1134 · Cited by 343
Profiling drug-like properties in discovery research
Di, L., & Kerns, E. H. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00055-3 · Cited by 278
Self-citationP-Glycoprotein Limits the Brain Penetration of Nonsedating but not Sedating H1-Antagonists
Chen, C., Hanson, E., Watson, J. W., & Lee, J. S. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.3.312 · Cited by 227
The Madin Darby Canine Kidney (MDCK) Epithelial Cell Monolayer as a Model Cellular Transport Barrier
Cho, M. J., Thompson, D. P., Cramer, C. T., Vidmar, T. J., & Scieszka, J. F. (1989) · Pharmaceutical Research · doi:10.1023/a:1015807904558 · Cited by 194
Lennernäs, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.016 · Cited by 159
Goh, L.-B., Spears, K. J., Yao, D., Ayrton, A., Morgan, P., Wolf, C. R., & Friedberg, T. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01355-2 · Cited by 157
Zhou, L., Schmidt, K., Nelson, F. R., Zelesky, V., Troutman, M. D., & Feng, B. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024489 · Cited by 154
Self-citationCell cultures as tools in biopharmacy
Braun, A., Hämmerle, S. P., Suda, K., Rothen‐Rutishauser, B., Günthert, M., Krämer, S. D., & Wunderli‐Allenspach, H. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00164-0 · Cited by 153
Pharmacokinetics and Metabolism in Drug Design
Smith, D. A., Waterbeemd, H. V. D. 1., & Walker, D. K. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00124-7 · Cited by 112
Kuteykin‐Teplyakov, K. B., Luna‐Tortós, C., Ambroziak, K., & Löscher, W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00801.x · Cited by 110
Janiszewski, J. S., Rogers, K. J., Whalen, K. M., Cole, M. J., Liston, T. E., Duchoslav, E., & Fouda, H. G. (2001) · Analytical Chemistry · doi:10.1021/ac0013251 · Cited by 103
Self-citationBiopharmaceutics Classification System: Validation and Learnings of an in Vitro Permeability Assay
Thiel-Demby, V. E., Humphreys, J. E., Williams, L. A. S. J., Ellens, H. M., Shah, N., Ayrton, A. D., & Polli, J. W. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800122b · Cited by 98
Evaluation of in vitro brain penetration: Optimized PAMPA and MDCKII-MDR1 assay comparison
Carrara, S., Reali, V., Misiano, P., Dondio, G. M., & Bigogno, C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.057 · Cited by 66
Comparison of in vitro cell models in predicting in vivo brain entry of drugs
Hakkarainen, J. J., Jalkanen, A. J., Kääriäinen, T. M., Keski‐Rahkonen, P., Venäläinen, T., Hokkanen, J., Mönkkönen, J., Suhonen, M., & Forsberg, M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.09.016 · Cited by 59
A 96-Well Efflux Assay To Identify ABCG2 Substrates Using a Stably Transfected MDCK II Cell Line
Xiao, Y., Davidson, R. E., Smith, A., Pereira, D. A., Zhao, S. X., Soglia, J. R., Gebhard, D. F., de Morais, S., & Duignan, D. B. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050088t · Cited by 48
Self-citationZhang, Y., Li, N., Brown, P. W., Ozer, J. S., & Lai, Y. (2011) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.5026 · Cited by 47
Self-citation
Cited by
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
Owen, D. R., Allerton, C. M. N., Anderson, A. S., Aschenbrenner, L., Avery, M., Berritt, S., Boras, B., Cardin, R. D., Carlo, A., Coffman, K. J., et al. (2021) · Science · doi:10.1126/science.abl4784 · Cited by 2,033
Self-citationGetting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins
Yang, N. J., & Hinner, M. J. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2272-7_3 · Cited by 826
Central nervous system multiparameter optimization desirability: Application in drug discovery
Wager, T. T., Hou, X., Verhoest, P. R., & Villalobos, A. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00029 · Cited by 653
Orally Absorbed Cyclic Peptides
Nielsen, D. S., Shepherd, N. E., Xu, W., Lucke, A. J., Stoermer, M. J., & Fairlie, D. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00838 · Cited by 445
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Dallavalle, S., Dobričić, V., Lazzarato, L., Gazzano, E., Machuqueiro, M., Pajeva, I., Tsakovska, I., Zidar, N., & Fruttero, R. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100682 · Cited by 318
Metadata
- Authors
- Di, L., Whitney‐Pickett, C., Umland, J. P., Zhang, H., Zhang, X., Gebhard, D. F., Lai, Y., Federico, J. J., Davidson, R. E., Smith, R., Reyner, E. L., Lee, C., Feng, B., Rotter, C., Varma, M. V., Kempshall, S., Fenner, K., El‐kattan, A. F., Liston, T. E., & Troutman, M. D.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 100
- Issue
- 11
- Pages
- 4974-4985
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W1988137261
- Cited by
- 313
- References
- 30
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.